Company news: Pfizer and PhRMA

Share this article:
Pfizer and Shanghai Pharmaceutical Co. are partnering for a possible Pfizer product launch in China. The companies already co-promote pediatric flu vaccine Prevenar in China.

PhRMA announced its board leadership for the coming year. Sanofi-Aventis CEO Christopher Viehbacher will continue as board chairman of the trade group, while Lilly chief John Lechleiter becomes chairman-elect and Celgene CEO Robert Hugin board treasurer. Viehbacher stepped into the role last year when then-chairman Jeff Kindler abruptly left Pfizer.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions